glp-1 for alzheimer's The potential mechanisms of on disease GLP-1 Drug Fails to Quell

GLP-1 ,

An no se ha empezado a comercializar en Espaa, donde solo est disponible Ozempic, con el mismo principio activo, pero financiado solo para personas con diabetes tipo 2

By comorbidity, including CKD, incident rates for hyperkalemia per 100 person years was 5.43 for people with type 2 diabetes, 8.7 for heart failure, 4.03 for people taking an ACEi or ARB, and 7.66 taking a steroidal MRA [21]

although human relevance remains uncertain, patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2) are generally advised not to use GLP-1 RAs